AI/ML Innovation Introduces Quantum Soma Strategy with Dynex Quantum Technologies for Contactless Quantum Biosensing Platform

On September 21, 2026, AI/ML Innovations and Dynex Quantum Technologies have started the Quantum Soma Initiative to create a contactless quantum biosensing platform. This project brings together quantum sensing and artificial intelligence to study physiological signals without using outdated physical sensors.

The company is working on a prototype and will assess whether the technology can be used for other biosensing purposes. The first commitment is to detect and analyze the magnetic signature of the human core. If it works, the platform could open up new ways to monitor health, support biological research, and utilize AI to interpret sensitive physiological data.

Impact on the Digital Health Sector  

The global digital health market size is calculated at USD 420.08 billion in 2025 and is predicted to increase from USD 483.07 billion in 2026 to approximately USD 1,171.24 billion by 2035, expanding at a CAGR of 10.8% from 2026 to 2035.

According to Precedence Research, the technology might one day be put to use in wellness monitoring, sleep studies, the tracking of movement, and in other healthcare frameworks that require continuous physiological data. Quantum Soma could have an effect on the healthcare industry by providing a means of monitoring physiological activity without having to touch the body.

 Its initial application involves cardiological health research into non-contact methods for tracking heart signals. For healthcare providers, this platform has to demonstrate that it can give reliable results, pass clinical tests, function consistently, and observe with regulatory standards. At present, the initiative is a research opportunity and not a medical tool ready for use.

Impact on the Quantum Technology Sector

The global quantum technology market size is calculated at USD 1.62 billion in 2025 and is predicted to increase from USD 1.99 billion in 2026 to approximately USD 11.12 billion by 2035, expanding at a CAGR of 21.24% from 2026 to 2035.

According to Precedence Research, quantum sensors can detect very small variations in magnetic fields by offering real-time analysis. This initiative has the potential to expand the range of applications for quantum sensing by applying advanced NV-diamond technology to biological measurements.  Quantum Soma includes an important software component by combining precise quantum measurements with signal interpretation based on AI. This combination may promote further development of quantum-enabled biosensing technologies and show how quantum hardware can function together with artificial intelligence. However, its long-term importance will ultimately depend on whether the prototype tests are able to prove useful sensitivity, stability, scalability, and practical operation.

Impact on the Biosensors Sector

The global biosensors market size is valued at USD 33.16 billion in 2025 and is predicted to increase from USD 35.81 billion in 2026 to approximately USD 64.54 billion by 2035, expanding at a CAGR of 6.89% from 2026 to 2035.

According to Precedence Research, to replace the dependence on electrodes or wearable sensors, the system aims to gather information through contactless quantum measurements. For the AI and digital health industries, Quantum Soma could create a new kind of physiological data that can be analyzed intelligently.

AI could then find patterns in these complex signals and turn raw sensor data into useful insights. If development goes well, this approach could lead to new opportunities of monitoring health and analyzing biosignals with AI. Overall, its commercial success will depend on data quality, processing performance, interoperability, privacy, and real-world testing.

Expert Opinion

According to expert opinion, Quantum Soma is an interesting combination of quantum sensing, artificial intelligence, and biological measurement, and its true significance will lie in the technical achievements rather than just in the announcement itself. There are considerable engineering difficulties involved in detecting weak physiological magnetic signals in real-world settings, especially when the background electromagnetic interference and other kinds of noise have to be dealt with.

Should these challenges be overcome, the technology might enable new research paths in the field of contactless biosensing. The prototype development stage should offer valuable evidence regarding sensitivity, repeatability, accuracy, and scalability. At this stage, the project is an experimental effort target at developing the technology, with possible commercial applications in the longer term.